Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2000
05/25/2000WO2000029593A1 Truncated nucleic acid sequences of the lettuce mosaic virus capsid gene and their use
05/25/2000WO2000029583A2 Immunoglobulin superfamily proteins
05/25/2000WO2000029582A2 Cell surface receptor antigen vaccines
05/25/2000WO2000029581A1 Human tslp dna and polypeptides
05/25/2000WO2000029580A1 Calcium binding protein
05/25/2000WO2000029579A1 Mammalian chondromodulin-like protein
05/25/2000WO2000029578A1 Cloning and characterization of two m-rna transcription factors
05/25/2000WO2000029577A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
05/25/2000WO2000029576A1 Lipocalin homologs
05/25/2000WO2000029575A1 Novel human wnt gene
05/25/2000WO2000029574A2 Inflammation-associated genes
05/25/2000WO2000029573A2 Adenoviral vectors
05/25/2000WO2000029572A1 Proteins maguin
05/25/2000WO2000029571A1 Gene encoding novel transmembrane protein
05/25/2000WO2000029570A1 Novel protein and utilization thereof
05/25/2000WO2000029569A1 Methods of diagnosing or treating neurological diseases
05/25/2000WO2000029567A1 Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof
05/25/2000WO2000029566A1 Promoters for gene expression in the roots of plants
05/25/2000WO2000029564A2 Human glycine transporter type 2
05/25/2000WO2000029561A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
05/25/2000WO2000029559A1 Kell protein proteolytic activity
05/25/2000WO2000029448A2 Human proteins having hydrophobic domains and dnas encoding these proteins
05/25/2000WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000WO2000029444A1 Generation of antibodies using polynucleotide vaccination in avian species
05/25/2000WO2000029441A1 Novel g protein-coupled receptor protein, its dna and ligand thereof
05/25/2000WO2000029440A1 Methods of conversion of interferon isoforms and products thereof
05/25/2000WO2000029439A1 The cxc chemokine h174 and methods for preventing damage to the nervous system
05/25/2000WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000WO2000029437A1 HYPOXIA-INDUCIBLE FACTOR 1α HIF-1α VARIANTS AND METHODS FOR IDENTIFYING HIF-1α MODULATORS
05/25/2000WO2000029436A1 Protein amsh and cdna thereof
05/25/2000WO2000029435A1 12 human secreted proteins
05/25/2000WO2000029434A2 PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF
05/25/2000WO2000029433A2 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines
05/25/2000WO2000029432A1 Heliobacter pylori antigen
05/25/2000WO2000029430A1 Ring finger protein zapop3
05/25/2000WO2000029429A2 Endoplasmic reticulum stress transcription factors atf6 and creb-rp
05/25/2000WO2000029428A2 5t4 tumour-associated antigen for use in tumour immunotherapy
05/25/2000WO2000029427A2 Antennapedia homeodomain helix 3 derived translocation vectors
05/25/2000WO2000029426A1 Compositions and methods for controlling plant pests
05/25/2000WO2000029423A1 G protein-coupled receptor resembling the leukotriene b4 receptor
05/25/2000WO2000029422A1 31 human secreted proteins
05/25/2000WO2000029012A2 Methods of alleviating cancer symptoms
05/25/2000WO2000029008A2 Hiv-specific t-cell induction
05/25/2000WO2000029000A1 Compositions and methods for recombinational cloning of nucleic acid molecules
05/25/2000WO2000028834A2 Method for reducing the viscosity of aqueous protein concentrates with polyols
05/25/2000WO2000028818A1 7-transmembrane receptor mouse kiaa0001
05/25/2000WO2000019988A8 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
05/25/2000WO2000018920A3 Tmof receptor and uses thereof
05/25/2000WO2000017372A3 Pineapple mealybug-associated wilt virus proteins and their uses
05/25/2000WO2000017236A3 Apoptosis related protein and uses therefor
05/25/2000WO2000017233A3 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
05/25/2000WO2000015818A3 Plant prohibitin genes and their use
05/25/2000WO2000015816A3 Maize replication protein a
05/25/2000WO2000015798A3 Mammalian transforming growth factor beta - 9 (ztgfss9)
05/25/2000WO2000015788A3 Dna sequence encoding oncofetal ferritin protein
05/25/2000WO2000015247A3 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
05/25/2000WO2000014228A8 Neutral amino acid transporter and gene thereof
05/25/2000WO2000014205A3 Methods for generating high titer helper-free preparations of released recombinant aav vectors
05/25/2000WO2000012690A3 Laminin 5 for treatment of bone defects
05/25/2000WO2000009148A9 Vascular endothelial growth factor 3
05/25/2000WO2000008443A9 Multiple frequency fluorescence lifetime imaging
05/25/2000WO2000008153A3 Arf-p19, a novel regulator of the mammalian cell cycle
05/25/2000WO2000007545A8 Apoptosis proteins
05/25/2000WO2000004051A3 Growth differentiation factor promoter and uses therefor
05/25/2000WO2000001801A9 Ftsz multimeric proteins and their uses
05/25/2000WO2000001410A9 Methods of inhibiting proliferative diseases by inhibiting tgf-beta mediated angiogenesis
05/25/2000WO2000000825A9 Detection and modulation of cellular immunity to immune privileged antigens
05/25/2000WO1999055849A8 Tyrosine phosphatase ia-2, gad and rotavirus vp7 immunity
05/25/2000WO1999051762A9 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
05/25/2000DE19853167A1 Wäßrige Proteinkonzentrate Aqueous protein concentrates
05/25/2000DE19840263C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
05/25/2000CA2369119A1 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
05/25/2000CA2351874A1 G protein-coupled receptor resembling the leukotriene b4 receptor
05/25/2000CA2351729A1 Cell surface receptor antigen vaccines
05/25/2000CA2351637A1 Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof
05/25/2000CA2351622A1 Polypeptide
05/25/2000CA2351576A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000CA2351524A1 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumour vaccines
05/25/2000CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000CA2351313A1 Immunoglobulin superfamily proteins
05/25/2000CA2351312A1 Novel human wnt gene
05/25/2000CA2351161A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000CA2351146A1 The cxc chemokine h174 and methods for preventing damage to the nervous system
05/25/2000CA2350919A1 Antennapedia homeodomain helix 3 derived translocation vectors
05/25/2000CA2350911A1 Hiv-specific t-cell induction
05/25/2000CA2350830A1 Hypoxia-inducible factor 1.alpha. hif-1.alpha. variants and methods for identifying hif-1.alpha. modulators
05/25/2000CA2350785A1 31 human secreted proteins
05/25/2000CA2350782A1 Compositions and methods for controlling plant pests
05/25/2000CA2350698A1 Human glycine transporter type 2
05/25/2000CA2350623A1 Mammalian chondromodulin-like protein
05/25/2000CA2350603A1 Ring finger protein zapop3
05/25/2000CA2350415A1 Inflammation-associated genes
05/25/2000CA2350391A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000CA2350389A1 Calcium binding protein
05/25/2000CA2350228A1 Novel g protein-coupled receptor protein, its dna and ligand thereof
05/25/2000CA2350186A1 Promoters for gene expression in the roots of plants
05/25/2000CA2350111A1 Generation of antibodies using polynucleotide vaccination in avian species
05/25/2000CA2349869A1 Novel protein and utilization thereof
05/25/2000CA2349762A1 Human tslp dna and polypeptides
05/25/2000CA2349618A1 Compositions and methods relating to the peroxisomal proliferator activated receptor-.alpha. mediated pathway
1 ... 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 ... 2916